Nuclear factor-?B1: Regulation and function

Abstract The transcription factor NF-κB is a critical regulator of many cellular processes including cell survival and inflammation. NF-κB functions as a hetero- or homo-dimer which can be formed from five NF-κB subunits, NF-κB1 (p50 and its precursor p105), NF-κB2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. The most studied dimer is p50:p65, which is activated by the classical pathway and usually promotes gene expression. Activation of p50:p65 is linked with cell survival and promoting inflammation. This review provides a detailed overview of the structure, synthesis and function of the lesser characterised NF-κB subunit; NF-κB1 (p105 and p50). The diverse interactions of NF-κB1 with co-activators, co-repressors and other signaling networks that influence NF-κB1 gene expression are discussed. Finally the anti-inflammatory actions of NF-κB1 signaling will be assessed and the crucial need to design novel therapeutic drugs which exploit and amplify the anti-inflammatory actions of p50 will be explored.

[1]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[2]  Mark Baer,et al.  Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50 , 1998, Molecular and Cellular Biology.

[3]  C. Scheidereit,et al.  NF‐κB p105 is a target of IκB kinases and controls signal induction of Bcl‐3–p50 complexes , 1999 .

[4]  G. Topulos,et al.  Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. , 2003, American journal of respiratory and critical care medicine.

[5]  Hideaki Ishikawa,et al.  Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-κB1) but Expressing p50 , 1998, The Journal of experimental medicine.

[6]  J. Caamaño,et al.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo , 1996, Molecular and cellular biology.

[7]  H. Young,et al.  BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages* , 2004, Journal of Biological Chemistry.

[8]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[9]  Shao-Cong Sun,et al.  NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. , 2003, Molecular cell.

[10]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[11]  W. Greene,et al.  Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome , 1998, Cell.

[12]  C. Scheidereit,et al.  The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators , 1999, Oncogene.

[13]  Xia Zhang,et al.  NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages* , 2006, Journal of Biological Chemistry.

[14]  H. Shu,et al.  Casper/c-FLIP is physically and functionally associated with NF-κB1 p105 , 2003 .

[15]  Susan J Wilson,et al.  Nuclear Factor-(cid:2) B1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury , 2022 .

[16]  C. Müller,et al.  The Histone Octamer Is Invisible When NF-κB Binds to the Nucleosome* , 2004, Journal of Biological Chemistry.

[17]  G. Ghosh,et al.  The 20S proteasome processes NF‐κB1 p105 into p50 in a translation‐independent manner , 2006, The EMBO journal.

[18]  R. Ricciardi,et al.  Phosphorylation of Serine 337 of NF-κB p50 Is Critical for DNA Binding* , 2003, Journal of Biological Chemistry.

[19]  M. Mattson,et al.  Neuroprotective role for the p50 subunit of NF-κB in an experimental model of Huntington’s disease , 2000, Journal of Molecular Neuroscience.

[20]  M. Robinson,et al.  Kinase Mitogen-activated Protein Kinase Tpl-2/mek/extracellular Signal-regulated Lipopolysaccharide Activation of the Supplemental Material , 2004 .

[21]  S. Yu,et al.  Age-related neural degeneration in nuclear-factor κB p50 knockout mice , 2006, Neuroscience.

[22]  P. Sandy,et al.  Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability* , 2003, Journal of Biological Chemistry.

[23]  H. Carlsen,et al.  Gene Deletion of NF-κB p105 Enhances Neointima Formation in a Mouse Model of Carotid Artery Injury , 2006, Cardiovascular Drugs and Therapy.

[24]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.